Global Agriculture Synthetic Biology Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

The Agriculture Synthetic Biology market is experiencing robust expansion, with market size projected to increase from 2023 to 2030, demonstrating a consistent year-over-year growth rate of 17.30% Agriculture Synthetic Biology Market Size, Share, Competitive Landscape and Trend Analysis Report, by Types (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism), by applications (Healthcare, Non-healthcare) ,by Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies) And regions (North America(United States, Canada, Mexico), South America(Brazil, Argentina, Chile, Rest of South America), Europe(Germany, France, Italy, United Kingdom, Benelux, Nordics, Rest of Europe), Asia Pacific(China, Japan, India, South Korea, Australia, Southeast Asia, Rest of Asia-Pacific), MEA(Middle East, Africa)) : Industry Forecast and Opportunity Analysis for 2023 - 2030

The global agricultural synthetic biology market is a field of innovative areas wherein, through the application of engineering principles, organisms can be designed and modified to improve agricultural practices. The underlying technology behind this includes the modification of genetic makeup in plants, animals, and microorganisms for enhancing their desirable traits such as yield, resistance to diseases, and nutritional content. Market drivers: High demand for sustainable and efficient food production, climate change, and increasing world population have thrust synthetic biology as an innovative solution to address such problems. Innovative solutions are drought-resistant crops, nutrient-rich foods, and bio-based fertilizers. Expanding tech and the regulatory framework of its evolution are likely to propel the agricultural synthetic biology market.

Agriculture Synthetic Biology Report Highlights

Report Metrics	Details
Forecast period	2019-2030
Base Year Of Estimation	2023
Growth Rate	CAGR of 17.30%
By Product Type	Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism
Key Market Players	Bota Biosciences Inc. Codexis, Inc. Creative Biogene. Creative Enzymes. Enbiotix, Inc. Eurofins Scientific Illumina, Inc. Merck Kgaa (Sigma-Aldrich Co. Llc) New England Biolabs Novozymes Pareto Bio, Inc. Scarab Genomics, Llc Synthego Synthetic Genomics Inc. Thermo Fisher Scientific, Inc.
By Region	North America(United States, Canada, Mexico) South America(Brazil, Argentina, Chile, Rest of South America) Europe(Germany, France, Italy, United Kingdom, Benelux, Nordics, Rest of Europe) Asia Pacific(China, Japan, India, South Korea, Australia, Southeast Asia, Rest of Asia-Pacific) MEA(Middle East, Africa)

Agriculture Synthetic Biology Market Trends

Agriculture synthetic biology is emerging as a rapidly growing market based on the trends of sustainability and productivity related to crops. A prime area of development involves genetically engineered microbes and plants that are intended to enhance the productivity of crops, reduce their susceptibility to pests, and make crops more resilient in harsh environments—like in conditions of drought or poor soil. In synthetic biology, therefore, scientists can design living organisms by altering their plant genomes and engineering plants and friendly microorganisms so that they can naturally improve soil fertility, reduce the usage of chemical fertilizers, and reduce greenhouse gas emissions. This trend can be aligned with an increasing demand for environmentally friendly farming solutions put forward by the world at large, considering that food demands sustain the world's population. Biopesticides, biofertilizers, and other growth regulators created through synthetic biology are now being produced from bio-based agricultural inputs. These biologically derived inputs promise greener alternatives to traditional chemicals to appeal to farmers as well as consumers concerned about organic and sustainable agriculture. The trend speaks to a move toward more resilient and resource-efficient practices in agriculture.

Agriculture Synthetic Biology Market Leading Players

The key players profiled in the report are Bota Biosciences Inc., Codexis, Inc., Creative Biogene., Creative Enzymes., Enbiotix, Inc., Eurofins Scientific, Illumina, Inc., Merck Kgaa (Sigma-Aldrich Co. Llc), New England Biolabs, Novozymes, Pareto Bio, Inc., Scarab Genomics, Llc, Synthego, Synthetic Genomics Inc., Thermo Fisher Scientific, Inc.

Growth Accelerators

Market drivers: Increasing demand to have sustainable, efficient farming solutions for food security. The global population puts pressure on agricultural systems to produce more with fewer resources. They range from genetically engineered crops that are more tolerant of pests and diseases and droughts, hence more yields at a lower dependency on chemical pesticides and fertilizers. All these are steps that help steer agricultural practices towards greater sustainability while complying with changed regulatory tendencies that are increasingly environmental. There's a fundamental driver from the accelerating development of biotechnological tools, such as CRISPR and gene-editing techniques, which did significantly enhance the capabilities of synthetic biology in agriculture. These tools further empower plant breeding and soil microbiome crop management with precise genetic modifications to better resilience in crops, enhanced nutritional profiles, and optimized growth rates.

Agriculture Synthetic Biology Market Segmentation analysis

The Global Agriculture Synthetic Biology is segmented by Type, Application, and Region.
By Type, the market is divided into Distributed Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism . The Application segment categorizes the market based on its usage such as Healthcare, Non-healthcare. Geographically, the market is assessed across key Regions like North America(United States, Canada, Mexico), South America(Brazil, Argentina, Chile, Rest of South America), Europe(Germany, France, Italy, United Kingdom, Benelux, Nordics, Rest of Europe), Asia Pacific(China, Japan, India, South Korea, Australia, Southeast Asia, Rest of Asia-Pacific), MEA(Middle East, Africa) and others, each presenting distinct growth opportunities and challenges influenced by the regions.

Competitive Landscape

In terms of market competition, a few major players in agricultural synthetic biology comprise Bayer AG, Syngenta AG, Corteva Agriscience, BASF SE, and Monsanto Company. The firms are investing extensively in R&D for the innovative products that could yield the maximum agricultural productivity without harming the environment. Strategic alliances and partnerships among biotech companies with research institutions are being followed to accelerate the new agribusiness technologies. The North American region currently holds the market lead position because of the longstanding agricultural sector and continued investment in biotechnology research. The Asia-Pacific region is experiencing growth rapidly, attributed to greater investment in agricultural innovation and a younger growing population that requires greater food production. In the face of added competition, companies are looking to engage in more responsible practices and strict regulation compliance to effectively navigate the complex landscape of agricultural biotechnology.

Challenges In Agriculture Synthetic Biology Market

One of the big challenges facing this agricultural synthetic biology market is regulatory uncertainty and tight approval processes. Synthetic biology, therefore, means genetic modifications of organisms, often leading to resultant social, environmental, food safety concerns, and ethical issues. Thus, in countries' regulatory affairs, views differ on whether GMOs should be allowed in agriculture or not, making this arena a very challenging one for companies wanting to introduce synthetic biology solutions in agriculture. This lack of consistent regulation would therefore slow product development and entry to the market, thereby limiting the scalability and adoption of such applications in agriculture. Public perception and consumer acceptance of synthetic biology in agriculture is another major challenge. Many consumers do not like GMOs and other bioengineered products, which might impact the further acceptance of applications such as engineered crops, biofertilizers, and pest-resistant plants. Thus, education will have to be transparent in dispelling these concerns. Clear labelling and clear benefits may overcome market growth scepticism.

Risks & Prospects in Agriculture Synthetic Biology Market

Promising opportunities in the synthetic biology market are found in enhanced crop productivity and resilience in agriculture. Synthetic biology can be used to engineer crops that possess enhanced resistance to drought and tolerance to pests as well as having better nutrient value. This technology presents a sustainable approach towards addressing the major global food security challenges since precise genetic modification ultimately improves yield and crop quality without increased use of chemical fertilizers and pesticides. Given the impact climate change will have on worse impacts in the forthcoming years, potentially devastating agricultural productivity, such a field as synthetic biology would necessarily open avenues for the development of crops that are better suited to stand such environmental stresses, especially for farmers in areas where adverse conditions of climate are experienced. One other emerging opportunity in the agricultural synthetic biology market includes bio-based fertilizers, pesticides, and soil enhancers. Synthetic biology-derived products can be engineered to target certain pests or deliver nutrients without the danger of harming either beneficial organisms or the environment. This supports sustainable farming, which is becoming increasingly required by the consumers in more eco-friendly food production.

Key Target Audience

Large agribusinesses, the firms engaged with seeds and crop protection, and food manufacturers looking for innovations that increase crop yield, enhance pest resistance, and improve soil health would be the major target customers of the agriculture synthetic biology market. These companies will use synthetic biology in the generation of genetically modified crops, bioengineered fertilizers, and biopesticides due to the envisaged challenges in crop production resulting from climate change, pest control, and nutrient deficiency. Other critical users of these synthetic biology-based solutions include agricultural producers, focused on sustainable agriculture and reduced reliance on chemical pesticides within their farmlands while at the same time developing tolerant crop varieties.,, Other key stakeholders involved are the research institutions, biotechnology companies, and regulatory bodies, which have a role in testing and refining the applications of agricultural biotechnology, including engineered microbes and gene-edited plants, which should be safe, effective, and in conformity with agricultural regulations. Technology developers and scientists in synthetic biology closely work with agribusinesses and farmers to construct eco-friendly, scalable solutions to farming—an issue not just for the planet but also for the food supply as the world continues to grow in population.

Merger and acquisition

The recent mergers and acquisitions in the agriculture synthetic biology market indicate further consolidation and strategic alliances to enhance innovation and expand product offerings. In February 2023, Sherlock Biosciences acquired a company called Sense Bio detection, looking to accelerate the development of faster molecular testing solutions that prove critical in agricultural diagnostics. This acquisition has enhanced the ability of Sherlock to provide low-cost and accurate diagnostics, which is crucial for improving crop health and yield by acting early. Similarly, Ginkgo Bioworks has had its fair share of expansion; in July 2023, for example, it entered a partnership with Sojitz Corporation to explore synthetic biology as a route toward developing ecologically friendly production processes that may be a way forward to more environmentally friendly cultivation practices. Further, Merck KGaA also generated much attention through the acquisition of AmpTec during early 2021. The acquisition is aimed at beefing up its synthetic biology space by developing improved mRNA capabilities. Specifically, mRNA technology is being explored widely for the development of crops that are resistant to diseases. The market has huge investments from major players like Novozymes and Amyris, both of which have been making several acquisitions to bolster their product portfolios and R&D capabilities.